Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Operating Income (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Operating Income data on record, last reported at $2.6 million in Q3 2025.

  • For Q3 2025, Operating Income fell 21.87% year-over-year to $2.6 million; the TTM value through Sep 2025 reached $11.9 million, up 6618.08%, while the annual FY2024 figure was $13.6 million, 479.45% up from the prior year.
  • Operating Income reached $2.6 million in Q3 2025 per UTMD's latest filing, down from $3.2 million in the prior quarter.
  • Across five years, Operating Income topped out at $5.1 million in Q3 2022 and bottomed at -$12.1 million in Q4 2022.
  • Average Operating Income over 5 years is $2.4 million, with a median of $3.9 million recorded in 2021.
  • Peak YoY movement for Operating Income: surged 168.28% in 2021, then plummeted 335.87% in 2022.
  • A 5-year view of Operating Income shows it stood at $5.1 million in 2021, then plummeted by 335.87% to -$12.1 million in 2022, then increased by 13.33% to -$10.5 million in 2023, then skyrocketed by 127.94% to $2.9 million in 2024, then dropped by 10.85% to $2.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Income were $2.6 million in Q3 2025, $3.2 million in Q2 2025, and $3.2 million in Q1 2025.